Much ado about nothing? Recent FDA alerts and NovoNordisk lawsuits
Due to the blockbuster weight loss drugs Ozempic, Wegovy and Mounjaro going on the FDA Shortage List, compounding pharmacies are legally allowed to make duplicates of these name brand drugs without risk of patent infringement. And even though NovoNordisk, the maker of Ozempic and Wegovy, admits they can’t keep up with demand, they’re trying everything […]